Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Uterus Transplantation From Live Donor (utx)

This study is ongoing, but not recruiting participants.
The Swedish Research Council
Information provided by (Responsible Party):
Mats Brännström, Sahlgrenska University Hospital, Sweden Identifier:
First received: April 23, 2013
Last updated: November 29, 2016
Last verified: November 2016

Uterus transplantation, as a possible future treatment for uterine factor infertility, has been developed in animal species during the last decade.

The study protocol includes transplantation of the uterus from a live donor (mother, relative, friend) into women with absolute uterine factor infertility (lack of uterus from birth or due to life saving hysterectomy).The recipient will be treated by standard immunosuppression and transfer of embryos (acquired by IVF before surgery) will be attempted when at least 12 months have passed from transplantation. Approval for a case series including up to 10 patients has been acquired.

Condition Intervention
Primary Uterine Infertility
Procedure: uterine transplantation

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Prospective Case Series of Human Uterus Transplantation From Live Donor

Resource links provided by NLM:

Further study details as provided by Mats Brännström, Sahlgrenska University Hospital, Sweden:

Primary Outcome Measures:
  • surviving transplants (12 months) [ Time Frame: up to 3 years after transplantation ]

Secondary Outcome Measures:
  • pregnancy rate [ Time Frame: up to 3 years after transplantation ]

Other Outcome Measures:
  • live birth rate [ Time Frame: up to 4 years after transplantation ]

Estimated Enrollment: 10
Study Start Date: September 2012
Estimated Study Completion Date: April 2018
Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Uterine transplantation
Patients undergo transplantation of the uterus from live donor.
Procedure: uterine transplantation
Transplantation of the uterus from live donor and IVF treatment.

Detailed Description:
The study is ongoing, with inclusion of 9 patients.

Ages Eligible for Study:   18 Years to 39 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • less than 39 years
  • good general health

Exclusion Criteria:

  • poor ovarian resaerve or older than 39 years
  • systemic or psychiatric disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01844362

Mats Brännström
Göteborg, Sweden, SE-41345
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
The Swedish Research Council
Principal Investigator: Mats Brännström, MD, PhD Göteborg University
  More Information


Responsible Party: Mats Brännström, Professor, Sahlgrenska University Hospital, Sweden Identifier: NCT01844362     History of Changes
Other Study ID Numbers: utx-ld
Study First Received: April 23, 2013
Last Updated: November 29, 2016
Individual Participant Data  
Plan to Share IPD: Yes
Plan Description: Scientific publications

Keywords provided by Mats Brännström, Sahlgrenska University Hospital, Sweden:

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female processed this record on May 25, 2017